2365-2411

Pharmaceutical Technology in Hospital Pharmacy

Walter de Gruyter GmbH

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 158 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact158 DOIs
2

Add license metadata to 129 records

License metadata tells indexers and readers how each article may be reused.

High impact129 DOIs
3

Add abstracts to 49 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact49 DOIs

DOIs for this ISSN

Showing the top 5 of 174 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Physical Compatibility of Intravenous Drugs Commonly Used in… (10.1515/pthp-2019-0005)
ORCID License
69.01 23
2 Stability Studies: A Scientific Mission of the Hospital Phar… (10.1515/pthp-2017-0032)
Abstract ORCID License
67.73 7
3 Particulate Matter in Injectable Drugs: Evaluation of Risks… (10.1515/pthp-2016-0004)
ORCID License
66.11 20
4 Automated Compounding of Intravenous Therapy in European Cou… (10.1515/pthp-2019-0008)
ORCID License
65.05 19
5 Stability of midazolam and noradrenaline stored in cyclic ol… (10.1515/pthp-2017-0013)
Abstract References ORCID License
60.21 3
6 GERPAC Consensus Conference – Guidance on the Assignment of… (10.1515/pthp-2020-0001)
References ORCID
60.21 15
7 Qualification and Performance Evaluation of an Automated Sys… (10.1515/pthp-2018-0012)
ORCID License
52.07 10
8 Automation of Aseptic Sterile Preparation: Risk Analysis and… (10.1515/pthp-2019-0001)
ORCID License
52.07 10
9 New Approaches to Wipe Sampling Methods for Antineoplastic a… (10.1515/pthp-2016-0009)
ORCID License
50.00 9
10 Environmental and Product Contamination during the Preparati… (10.1515/pthp-2018-0018)
ORCID License
50.00 9
11 European Databases on Stability and Compatibility of Injecta… (10.1515/pthp-2019-0012)
ORCID License
50.00 9
12 Stability of Concentrated Solution of Vancomycin Hydrochlori… (10.1515/pthp-2017-0031)
ORCID License
47.71 8
13 Development and Preparation of Oral Suspensions for Paediatr… (10.1515/pthp-2018-0008)
ORCID License
45.15 7
14 Physicochemical Stability of Cefotaxime Sodium in Polypropyl… (10.1515/pthp-2019-0006)
ORCID License
45.15 7
15 Simulation: A Powerful Tool for Training Professional Skills… (10.1515/pthp-2015-0003)
ORCID License
42.25 6
16 Formulation of a 3-months Stability Oral Viscous Budesonide… (10.1515/pthp-2018-0005)
ORCID License
42.25 6
17 HPLC – Quality by Design Approach for Simultaneous Detection… (10.1515/pthp-2018-0011)
ORCID License
42.25 6
18 Impact of Physical Parameters on Dosing Errors due to a Syri… (10.1515/pthp-2017-0002)
ORCID License
38.91 5
19 Safe use of Dexamethasone in pediatrics: design and evaluati… (10.1515/pthp-2018-0003)
ORCID License
38.91 5
20 Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation (10.1515/pthp-2018-0025)
ORCID License
38.91 5
21 Controlling Risks in the Compounding Process of Individually… (10.1515/pthp-2019-0020)
ORCID License
38.91 5
22 Benefits of Wipe Sampling: Evaluation of Long-Term 5-Fluorou… (10.1515/pthp-2016-0010)
ORCID License
34.95 4
23 Rubber Coring of Injectable Medication Vial Stoppers: An Eva… (10.1515/pthp-2016-0015)
ORCID License
34.95 4
24 Criteria for Judging the Quality of a Publication on Physico… (10.1515/pthp-2017-0012)
ORCID License
34.95 4
25 Closed-loop Administration of General Anaesthesia: From Sens… (10.1515/pthp-2017-0017)
ORCID License
34.95 4
26 Stability of Ready-to-Administer and Ready-to-Use Epinephrin… (10.1515/pthp-2017-0024)
ORCID License
34.95 4
27 Physicochemical Stability of Extemporaneously Prepared Oral… (10.1515/pthp-2018-0007)
ORCID License
34.95 4
28 The Field of Pharmaceutical Technology in Hospitals is Broad (10.1515/pthp-2016-0014)
Abstract References ORCID License
30.10 1
29 A special issue dedicated to the GERPAC 2016 meeting (10.1515/pthp-2017-0016)
Abstract References ORCID License
30.10 1
30 Resolution CM/Res(2016)2 and Centralised Intra Venous Additi… (10.1515/pthp-2017-0023)
ORCID License
30.10 3
31 graphical-abstract (10.1515/pthp-2018-graphabs1)
Abstract References ORCID License
30.10 1
32 Assessment of an Online Training Tool for the Automated Unit… (10.1515/pthp-2019-0003)
ORCID License
30.10 3
33 Methods for the Study of Physical and Chemical Stability and… (10.1515/pthp-2019-0009)
ORCID License
30.10 3
34 Development of a Stability Indicating Method for Simultaneou… (10.1515/pthp-2018-0026)
License
26.98 11
35 Using Preliminary Risk Analysis (PRA) to Ensure Safety in th… (10.1515/pthp-2016-0006)
ORCID License
23.86 2
36 Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge… (10.1515/pthp-2016-0023)
ORCID License
23.86 2
37 Centrally Prepared Cytotoxic Drugs: What Is the Purpose of T… (10.1515/pthp-2017-0006)
ORCID License
23.86 2
38 Avoid Drug Incompatibilities: Clinical Context in Neonatal I… (10.1515/pthp-2017-0009)
ORCID License
23.86 2
39 Physicochemical Stability of Reconstituted Decitabine (Dacog… (10.1515/pthp-2017-0025)
ORCID License
23.86 2
40 A Sorption Study between Ophthalmic Drugs and Multi Dose Eye… (10.1515/pthp-2017-0026)
ORCID License
23.86 2
41 Physicochemical Stability of 5 mg/mL Pediatric Prednisone Or… (10.1515/pthp-2018-0001)
ORCID License
23.86 2
42 Evolution of the Stabilis<sup>®</sup> Database: Creation of… (10.1515/pthp-2018-0002)
ORCID License
23.86 2
43 Paediatric formulation: budesonide 0.1 mg/mL viscous oral so… (10.1515/pthp-2018-0004)
ORCID License
23.86 2
44 Physico-Chemical Stability of Sodium Thiosulfate Infusion So… (10.1515/pthp-2018-0015)
ORCID License
23.86 2
45 Validation of an HPLC Assay Method for Routine QC Testing an… (10.1515/pthp-2018-0022)
ORCID License
23.86 2
46 Emulsion Stability of Different Intravenous Propofol Formula… (10.1515/pthp-2019-0014)
License
23.86 8
47 Quality in Stability Testing (10.1515/pthp-2018-0010)
Abstract ORCID License
22.58 1
48 Y-site compatibility of intravenous medications commonly use… (10.1515/pthp-2022-0002)
ORCID
22.58 7
49 Development and characterization of paracetamol medicated lo… (10.1515/pthp-2020-0012)
ORCID
21.13 6
50 Physicochemical stability study of a biosimilar of Bevacizum… (10.1515/pthp-2022-0007)
ORCID
19.45 5